Patents Assigned to ZHEJIANG BOSSAN PHARMACEUTICAL CO., LTD.
  • EGFR kinase inhibitor and preparation method and use thereof
    Patent number: 10710979
    Abstract: The present invention provides an EGFR kinase inhibitor and a preparation method and use thereof. Specifically, the present invention provides a compound as shown in formula (I), the definition of each group therein being as described in the description. Said compound is an efficient EGFR inhibitor.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: July 14, 2020
    Assignee: ZHEJIANG BOSSAN PHARMACEUTICAL CO. LTD.
    Inventors: Dawei Ma, Qiang Yu, Junying Yuan, Hongguang Xia, Dongpo Cai, Kailiang Wang, Chen Zhang, Shanghua Xia
  • Anti-tumor use of anagrelide and derivatives thereof
    Patent number: 10105362
    Abstract: The present invention provides an anti-tumor use of Anagrelide and derivatives thereof and, more specifically, the present invention provides the use of Anagrelide and derivatives thereof in the preparation of pharmaceuticals or pharmaceutical compositions for the treatment or inhibition of tumors.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: October 23, 2018
    Assignee: ZHEJIANG BOSSAN PHARMACEUTICAL CO., LTD.
    Inventors: Qiang Yu, Jing He, Qing Zhang